196 related articles for article (PubMed ID: 28551813)
21. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
22. Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.
Braza F; Dugast E; Panov I; Paul C; Vogt K; Pallier A; Chesneau M; Baron D; Guerif P; Lei H; Laplaud DA; Volk HD; Degauque N; Giral M; Soulillou JP; Sawitzki B; Brouard S
J Am Soc Nephrol; 2015 Aug; 26(8):1795-805. PubMed ID: 25556168
[TBL] [Abstract][Full Text] [Related]
23. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of Helios, Neuropilin-1 and FoxP3 in head and neck squamous cell carcinoma (HNSCC) patients.
Adil AAM; Bommanabonia AK; Vaithy A; Kumar S; Waseem M; Jamal S; Ahmed N
3 Biotech; 2019 May; 9(5):178. PubMed ID: 30997315
[TBL] [Abstract][Full Text] [Related]
25. Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer.
Schott AK; Pries R; Wollenberg B
Int J Mol Med; 2010 Jul; 26(1):67-75. PubMed ID: 20514424
[TBL] [Abstract][Full Text] [Related]
26. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.
Pan X; Yuan X; Zheng Y; Wang W; Shan J; Lin F; Jiang G; Yang YH; Wang D; Xu D; Shen L
PLoS One; 2012; 7(4):e34662. PubMed ID: 22506043
[TBL] [Abstract][Full Text] [Related]
27. Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.
Li Z; Vermeire S; Bullens D; Ferrante M; Van Steen K; Noman M; Rutgeerts P; Ceuppens JL; Van Assche G
Inflamm Bowel Dis; 2015 Oct; 21(10):2418-28. PubMed ID: 26308438
[TBL] [Abstract][Full Text] [Related]
28. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
[TBL] [Abstract][Full Text] [Related]
29. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
[TBL] [Abstract][Full Text] [Related]
30. The role of recent thymic emigrant-regulatory T-cell (RTE-Treg) differentiation during pregnancy.
Wagner MI; Mai C; Schmitt E; Mahnke K; Meuer S; Eckstein V; Ho AD; Schaier M; Zeier M; Spratte J; Fluhr H; Steinborn A
Immunol Cell Biol; 2015 Nov; 93(10):858-67. PubMed ID: 25915117
[TBL] [Abstract][Full Text] [Related]
31. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
Roschupkina T; Juliusson G
Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496
[TBL] [Abstract][Full Text] [Related]
32. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
[TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma.
Hayashi T; Yoshikawa K; Suzuki S; Gosho M; Ueda R; Kazaoka Y
Clin Exp Dent Res; 2022 Feb; 8(1):152-159. PubMed ID: 34319010
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
35. Reduced CD4
Mirzakhani M; Shahbazi M; Akbari R; Oliaei F; Asgharpour M; Nikoueinejad H; Mohammadnia-Afrouzi M
Transpl Immunol; 2020 Jun; 60():101290. PubMed ID: 32240775
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T cells induce CD4
Ihara F; Sakurai D; Takami M; Kamata T; Kunii N; Yamasaki K; Iinuma T; Nakayama T; Motohashi S; Okamoto Y
Cancer Immunol Immunother; 2019 Dec; 68(12):1935-1947. PubMed ID: 31641795
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma.
Okuyama K; Naruse T; Yanamoto S
J Exp Clin Cancer Res; 2023 May; 42(1):114. PubMed ID: 37143088
[TBL] [Abstract][Full Text] [Related]
38. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
39. Significant augmentation of regulatory T cell numbers occurs during the early neonatal period.
Hayakawa S; Ohno N; Okada S; Kobayashi M
Clin Exp Immunol; 2017 Nov; 190(2):268-279. PubMed ID: 28677152
[TBL] [Abstract][Full Text] [Related]
40. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
